|
2011-12-13 |
2011-12-12 |
B
Purchase
|
CUBIST PHARMACEUTICALS INC
Large shareholder
|
7,908,727
+100.0%
4.25
USD 33,612,090
|
7,908,727
+100.0%
|
4.25
|
USD 33,612,090
|
|
|
2011-12-13 |
2011-12-09 |
B
Purchase
|
CUBIST PHARMACEUTICALS INC
Large shareholder
|
45,070,030
+104.1%
4.76
USD 214,533,343
|
45,070,030
+104.1%
|
4.76
|
USD 214,533,343
|
|
|
2011-12-13 |
2011-12-09 |
B
Purchase
|
CUBIST PHARMACEUTICALS INC
Large shareholder
|
1,729,130
+4.2%
4.25
USD 7,348,803
|
1,729,130
+4.2%
|
4.25
|
USD 7,348,803
|
|
|
2011-12-09 |
2011-12-08 |
B
Purchase
|
CUBIST PHARMACEUTICALS INC
Large shareholder
|
1,180,983
+2.9%
4.25
USD 5,019,178
|
1,180,983
+2.9%
|
4.25
|
USD 5,019,178
|
|
|
2011-12-09 |
2011-12-07 |
B
Purchase
|
CUBIST PHARMACEUTICALS INC
Large shareholder
|
4,306,129
+11.9%
4.25
USD 18,301,048
|
4,306,129
+11.9%
|
4.25
|
USD 18,301,048
|
|
|
2011-12-08 |
2011-12-06 |
B
Purchase
|
MADDEN DAVID
Non-Executive Director
|
18,425
+1.7%
4.66
USD 85,861
|
18,425
+1.7%
|
4.66
|
USD 85,861
|
|
|
2011-12-08 |
2011-12-06 |
B
Purchase
|
MADDEN DAVID
Non-Executive Director
|
61,650
+6.0%
4.65
USD 286,673
|
61,650
+6.0%
|
4.65
|
USD 286,673
|
|
|
2011-12-02 |
2011-12-02 |
B
Purchase
|
NICKELSON DONALD E
Non-Executive Director
|
35,000
+11.4%
4.62
USD 161,700
|
35,000
+11.4%
|
4.62
|
USD 161,700
|
|
|
2011-12-02 |
2011-12-02 |
B
Purchase
|
NICKELSON DONALD E
Non-Executive Director
|
100,000
+48.1%
4.67
USD 467,000
|
100,000
+48.1%
|
4.67
|
USD 467,000
|
|
|
2011-12-02 |
2011-12-02 |
B
Purchase
|
NICKELSON DONALD E
Non-Executive Director
|
72,896
+53.9%
4.73
USD 344,798
|
72,896
+53.9%
|
4.73
|
USD 344,798
|
|
|
2011-11-30 |
2011-11-22 |
B
Purchase
|
NICKELSON DONALD E
Non-Executive Director
|
2,643
+2.0%
4.58
USD 12,105
|
2,643
+2.0%
|
4.58
|
USD 12,105
|
|
|
2011-11-30 |
2011-11-21 |
B
Purchase
|
NICKELSON DONALD E
Non-Executive Director
|
24,461
+22.6%
4.59
USD 112,276
|
24,461
+22.6%
|
4.59
|
USD 112,276
|
|
|
2011-06-27 |
2011-06-27 |
B
Purchase
|
Webster Stephen W
SVP, Finance & CFO
Officer
|
10,000
+7.8%
1.88
USD 18,800
|
10,000
+7.8%
|
1.88
|
USD 18,800
|
|
|
2011-06-22 |
2011-06-15 |
B
Purchase
|
Limongelli John M
SVP, General Counsel & Secr.
Officer
|
3,010
+1.6%
1.80
USD 5,418
|
3,010
+1.6%
|
1.80
|
USD 5,418
|
|
|
2011-06-22 |
2011-06-14 |
B
Purchase
|
Limongelli John M
SVP, General Counsel & Secr.
Officer
|
13,190
+7.6%
1.90
USD 25,061
|
13,190
+7.6%
|
1.90
|
USD 25,061
|
|
|
2010-12-23 |
2010-12-23 |
B
Purchase
|
DOUGHERTY MICHAEL R
President & CEO
Executive Director
|
30,000
+5.1%
1.18
USD 35,400
|
30,000
+5.1%
|
1.18
|
USD 35,400
|
|
|
2010-10-29 |
2010-10-29 |
S
Sale
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
376
-0.5%
1.18
USD 445
|
376
-0.5%
|
1.18
|
USD 445
|
|
|
2010-10-29 |
2010-10-29 |
S
Sale
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
14
-0.5%
1.18
USD 17
|
14
-0.5%
|
1.18
|
USD 17
|
|
|
2010-10-29 |
2010-10-29 |
S
Sale
|
14159 capital (GP), LLC
Large shareholder
|
884
-0.5%
1.18
USD 1,046
|
884
-0.5%
|
1.18
|
USD 1,046
|
|
|
2010-10-29 |
2010-10-29 |
S
Sale
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
60
-0.5%
1.18
USD 71
|
60
-0.5%
|
1.18
|
USD 71
|
|
